Acadia Pharmaceuticals (ACAD) PT Lowered to $19 at Mizuho Securities
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $28.24 --0%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Join SI Premium – FREE
Mizuho Securities analyst Vamil Divan lowered the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $19.00 (from $27.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
- JPMorgan Downgrades Amcor Plc. (AMCR) to Neutral
- Entain PLC (ENT:LN) (GMVHF) PT Raised to GBP10.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
